Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer

Fleur Peters; Annemiek Peeters; Thierry van den Bosch; Antien Mooyaart; Jacqueline van de Wetering; M.G.H. Betjes; Carla Baan; Karin Boer

doi:10.1111/cei.13309

Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

43 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	341-351
Number of pages	11
Journal	Clinical & Experimental Immunology
Volume	197
Issue number	3
DOIs	https://doi.org/10.1111/cei.13309
Publication status	Published - 2019

Research programs

EMC MM-03-24-01
EMC MM-04-39-05

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/cei.13309

RePub-119007-OA.pdfFinal published version, 600 KB

http://hdl.handle.net/1765/119007

Cite this

@article{e5ddb4b50e3a4ed8b472488e2d989429,

title = "Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer",

author = "Fleur Peters and Annemiek Peeters and \{van den Bosch\}, Thierry and Antien Mooyaart and \{van de Wetering\}, Jacqueline and M.G.H. Betjes and Carla Baan and Karin Boer",

year = "2019",

doi = "10.1111/cei.13309",

language = "Undefined/Unknown",

volume = "197",

pages = "341--351",

journal = "Clinical \& Experimental Immunology",

issn = "0009-9104",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer

AU - Peters, Fleur

AU - Peeters, Annemiek

AU - van den Bosch, Thierry

AU - Mooyaart, Antien

AU - van de Wetering, Jacqueline

AU - Betjes, M.G.H.

AU - Baan, Carla

AU - Boer, Karin

PY - 2019

Y1 - 2019

U2 - 10.1111/cei.13309

DO - 10.1111/cei.13309

M3 - Article

C2 - 31059128

SN - 0009-9104

VL - 197

SP - 341

EP - 351

JO - Clinical & Experimental Immunology

JF - Clinical & Experimental Immunology

IS - 3

ER -